Study on the role of asialoglycoprotein receptor for human bone marrow mesenchymal stem cells against hepatitis B virus infection
10.3760/cma.j.issn.1000-6680.2010.08.002
- VernacularTitle:骨髓间充质干细胞对乙型肝炎病毒的易感性及与无涎糖蛋白受体的关系
- Author:
Chan XIE
;
Shibin XIE
;
Shaoquan ZHANG
;
Junqiang XIE
;
Bingliang LIN
;
Zhiliang GAO
- Publication Type:Journal Article
- Keywords:
Bone marrow cells;
Mesenchymal stem cells;
Hepatitis B virus;
Asialoglycoprotein receptor
- From:
Chinese Journal of Infectious Diseases
2010;28(8):455-460
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the susceptibility of bone marrow mesenchymal stem cell (BMSC) to hepatitis B virus (HBV) infection during induction toward hepatocyte and the role of asialoglycoprotein receptor (ASGPR) in BMSC HBV infection. Methods BMSC obtained from hepatitis B patients were tested for HBV infection and then cultured with HBV infectious serum in vitro and induced to differentiate into hepatocyte through exposure to hepatocyte growth factor (HGF), fibroblast growth factor-4(FGF-4), and epidermal growth factor(EGF). Subsequently these cells were determined for the presence of hepatitis B virus e antigen( HBeAg), hepatitis B virus surface antigen(HBsAg) and ASGPR. All experiments were repeated for 3 times in 5 different samples. The results were analyzed by non-parametric test. Results After 6 days of exposure, BMSC-derived hepatocyte-like cells expressed hepatic special genes and proteins, including alpha fetoprotein(AFP),cytokeratin18 (CK18), albumin (Alb), and manifested hepatocyte functions, including glycogen synthesis, urea secretion and albumin synthesis. Expressions of CK18 and Alb were increased, and AFP was decreased with time of induction. The BMSC were resistant to HBV infection both in vitro and in vivo or after induction toward hepatocyte. ASGPR expression level was low in BMSC, which was increased in the induced BMSC but still lower than that of the control HepG2 cells. Conclusions BMSC are resistant to HBV infection both in vitro and in vivo. The low level expression of ASGPR may be a reason for this.
